Niacin Tablet, Extended Release
Product Images NDC 50268-584

6 FDA label images from Avpak · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Niacin (NDC 50268-584). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4097803e-figure-01 (Niacin Extended Release Tablets 500 mg 1000 mg 1)

4097803e-figure-01 (Niacin Extended Release Tablets 500 mg 1000 mg 1)
Chemical structure diagram of the active ingredient Niacin, showing a pyridine ring with a carboxyl group and molecular weight of 123.11 g/mol displayed.*
FDA Label Image

3 (Table 3)

3 (Table 3)
The data table titled "Lipid Response to Niacin Extended-Release Therapy" presents mean percent changes from baseline to week 16 for various lipid parameters (TC, LDL-C, HDL-C, TG, Apo B) across different treatment groups including Niacin Extended-Release at doses of 1,000 mg, 1,500 mg, and 2,000 mg, as well as placebo. It also lists the number of patients in each group (n).*
FDA Label Image

4 (Able 4)

4 (Able 4)
A table titled 'Lipid Response in Dose-Escalation Study' showing mean percent change from baseline in lipid parameters (TC, LDL-C, HDL-C, TG, Apo B) for placebo and various doses of Niacin extended-release (500 mg, 1000 mg, 1500 mg, 2000 mg at bedtime). It includes patient numbers and notes on statistical significance compared to placebo after 24 weeks.*
FDA Label Image

7 (Table 7)

7 (Table 7)
Table showing the lipid response to Niacin extended-release in patients with low HDL-C. It presents baseline and week 19 values for total cholesterol (TC), LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), triglycerides (TG), and Apo B, including mean baseline levels and mean percent changes from baseline. The table includes notes on patient numbers and statistical significance of changes.*
FDA Label Image

1 (584 13)

1 (584 13)
Label for Niacin Extended-release Tablets 500 mg by AvPAK. The label shows a pack of 30 tablets (3 x 10) unit dose with Rx only designation. It includes storage instructions, pharmacist dispensing information, manufacturer details for AWKARE in Pulaski, TN, a barcode, and a QR code.*
FDA Label Image

1 (586 13)

1 (586 13)
Label for Niacin Extended-release Tablets, 1000 mg strength, Rx only, containing 30 tablets in unit dose packaging. The label includes NDC 50268-586-13 and indicates the product is manufactured for AvKARE, Inc., Pulaski, TN, under the AvPAK brand.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.